Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib

por Stjepanovic, Neda, Capdevila, Jaume
Publicado em 2014

Unmet Needs in the Field of Neuroendocrine Neoplasms of the Gastrointestinal Tract, Pancreas, and Respiratory System: Reports by the ENETS Group

por de Herder, Wouter W., Capdevila, Jaume
Publicado no Neuroendocrinology (2019)

Thyroid Cancer: Molecular Aspects and New Therapeutic Strategies

por Grande, Enrique, Díez, Juan José, Zafon, Carles, Capdevila, Jaume
Publicado em 2012

Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer

por Gupta, Anubha, Jarzab, Barbara, Capdevila, Jaume, Shumaker, Robert, Hussein, Ziad
Publicado no Br J Clin Pharmacol (2016)

A significant response to sunitinib in a patient with anaplastic thyroid carcinoma

por Grande, Enrique, Capdevila, Jaume, Díez, Juan José, Longo, Federico, Carrato, Alfredo
Publicado em 2013

Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report

por Cortés-Mateus, Karen S., Holub, Katarzyna, Racca, Fabricio, Grau, Juan José, Capdevila, Jaume
Publicado no Oncol Lett (2018)

Meta‐Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors

por Capdevila, Jaume, Hernando, Jorge, Perez‐Hoyos, Santiago, Roman‐Gonzalez, Alejandro, Grande, Enrique
Publicado no Oncologist (2019)

Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis...

por Sevilla, Isabel, Segura, Ángel, Capdevila, Jaume, López, Carlos, García-Carbonero, Rocío, Grande, Enrique
Publicado no BMC Cancer (2016)

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

por Grande, Enrique, Kreissl, Michael C., Filetti, Sebastiano, Newbold, Kate, Reinisch, Walter, Robert, Caroline, Schlumberger, Martin, Tolstrup, Lærke K., Zamorano, Jose L., Capdevila, Jaume
Publicado em 2013

Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-3 Trial

por Lombard-Bohas, Catherine, Yao, James C., Hobday, Timothy, Van Cutsem, Eric, Wolin, Edward M., Panneerselvam, Ashok, Stergiopoulos, Sotirios, Shah, Manisha H., Capdevila, Jaume, Pommier, Rodney
Publicado no Pancreas (2015)

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in dev...

por Garcia-Carbonero, Rocio, Garcia-Figueiras, Roberto, Carmona-Bayonas, Alberto, Sevilla, Isabel, Teule, Alex, Quindos, Maria, Grande, Enrique, Capdevila, Jaume, Aller, Javier, Arbizu, Javier, Jimenez-Fonseca, Paula
Publicado no Cancer Metastasis Rev (2015)

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents

por García-Alfonso, Pilar, Ferrer, Ana, Gil, Silvia, Dueñas, Rosario, Pérez, María Teresa, Molina, Raquel, Capdevila, Jaume, Safont, María José, Castañón, Carmen, Cano, Juana María, Lara, Ricardo
Publicado no Target Oncol (2015)

Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT

por Molla, Meritxell, Fernandez-Plana, Julen, Albiol, Santiago, Fondevila, Constantino, Vollmer, Ivan, Cases, Carla, Garcia-Criado, Angeles, Capdevila, Jaume, Conill, Carles, Fundora, Yliam, Fernandez-Martos, Carlos, Pineda, Estela
Publicado no J Clin Med (2021)

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

por Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J., Dutcus, Corina E., Song, James, Taylor, Matthew H., Kim, Sung-Bae, Krzyzanowska, Monika K., Capdevila, Jaume, Sherman, Steven I., Tahara, Makoto
Publicado no J Clin Endocrinol Metab (2016)

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

por Capdevila, Jaume, Teulé, Alexandre, Barriuso, Jorge, Castellano, Daniel, Lopez, Carlos, Manzano, Jose Luis, Alonso, Vicente, García‐Carbonero, Rocío, Dotor, Emma, Matos, Ignacio, Custodio, Ana, Casanovas, Oriol, Salazar, Ramon
Publicado no Oncologist (2018)

Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review

por Grande, Enrique, Díaz, Ángel, López, Carlos, Munarriz, Javier, Reina, Juan-José, Vera, Ruth, Bernárdez, Beatriz, Aller, Javier, Capdevila, Jaume, Garcia-Carbonero, Rocio, Jimenez Fonseca, Paula, Trapero-Bertran, Marta
Publicado no Ther Adv Endocrinol Metab (2019)

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

por Garcia‐Carbonero, Rocio, Marquez‐Rodas, Ivan, de la Cruz‐Merino, Luis, Martinez‐Trufero, Javier, Cabrera, Miguel Angel, Piulats, Jose Maria, Capdevila, Jaume, Grande, Enrique, Martin‐Algarra, Salvador, Berrocal, Alfonso
Publicado no Oncologist (2019)

Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey...

por Benavent, Marta, Sastre, Javier, Escobar, Ignacio García, Segura, Angel, Capdevila, Jaume, Carmona, Alberto, Sevilla, Isabel, Alonso, Teresa, Crespo, Guillermo, García, Lourdes, Canal, Neus, de la Cruz, Guillermo, Gallego, Javier
Publicado no Health Qual Life Outcomes (2021)

Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor — an update on neuroendocrine neoplasm’s treatment: A case report

por Mirallas, Oriol, Saoudi, Nadia, Gómez-Puerto, Diego, Riveiro-Barciela, Mar, Merino, Xavier, Auger, Cristina, Landolfi, Stefania, Blanco, Laia, Garcia-Burillo, Amparo, Molero, Xavier, Salcedo-Allende, Maria Teresa, Capdevila, Jaume
Publicado no World J Hepatol (2021)

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results of the RADIANT-3 Study

por Pommier, Rodney, Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Lam, Du, Kunz, Tiffany, Brandt, Ulrike, Capdevila, Jaume, De Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Yao, James C.
Publicado no Gastrointest Cancer Res (2014)